Factors related to treatment adherence in patients with tuberculosis in Pereira, Colombia, 2012-2013
Abstract
Introduction: According to the World Health Organization, the adherence to the tuberculosis treatment is the extent to which a patient’s medication taking coincides with the prescribed treatment. The sum of cured patients and those who have completed treatment (directly observed therapy strategy, DOTS) are pragmatic indicators of the adherence. The patients who do not complete treatment correspond to non-adherents. Objective: To determine the relationship between anti-tuberculosis treatment adherence and socio-demographic, economic, clinical, and drug-related objective and subjective factors in patients over 18 years of age. Materials and methods: This was a descriptive, cross-sectional study of 174 patient records of the tuberculosis control program and 15 semi-structured interviews to non-adherent patients during the period between June, 2012, and June, 2013. Results: The adherence in patients with pulmonary tuberculosis was 94.8%. It was higher in patients in the social security contributory regime (p=0.035). Non-adherence was 5.2%. Drug intolerance was higher in the group of non-adherent patients. The lack of family support, absenteeism in the workplace, economic impact and dissatisfaction with the timeliness and the care of the health institution, were important in the decision of non-adherence. Conclusions: Affiliation to the health system regime and drug tolerance were objective factors related to adherence to treatment. The social and economic burden of disease is a subjective factor associated with the decision of not adhering to treatment.
Downloads
References
Chaparro PE, García I, Guerrero MI, León CI. Situación de la tuberculosis en Colombia 2002. Biomédica. 2004;24 (Supl.1):102-14. http://dx.doi.org/10.7705/biomedica.v24i Supp%201.1309
Ministerio de Salud de Colombia. Guía de atención de la tuberculosis pulmonar y extrapulmonar. Bogotá: Opciones Gráficas Editores; 2002.
Organización Mundial de la Salud. Adherencia a los tratamientos a largo plazo. Pruebas para la acción. 2004. Fecha de consulta: 20 de agosto de 2014. Disponible en: http://www.paho.org/hq/index.php?option=com_docman&task =doc_view&gid=18722&Itemid.
Ministerio de la Protección Social, Organización Panamericana de la Salud, Instituto Nacional de Salud. Plan Estratégico Colombia Libre de Tuberculosis, 2010-2015. Fecha de consulta: 11 de agosto de 2013. Disponible en: http://www.paho.org/col/index.php?option=com_content &view=article&id=431:plan-estrategico-colombia-libre-de-tuberculosis-2010-2015&Itemid=361.
De la Parte M, Hurtado MP, Rivera M. Tuberculosis en el nuevo milenio. RFM. 2001;24:104-19.
Salazar C, Uribe M, Zuluaga W, Ríos J, Montes F. Factores de riesgo para el abandono del tratamiento contra la tuberculosis en la ciudad de Medellín. Enero de 2000-junio de 2001. Revista CES Medicina. 2004;18:26-33.
Awofeso N. Anti-tuberculosis medication side effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ. 2008;86:A-F. http://dx. doi.org/10.2471/BLT.07.043802
Cáceres FM, Orozco LC. Incidencia y factores asociados al abandono del tratamiento antituberculoso. Biomédica. 2007;27:498-504. http://dx.doi.org/10.7705/biomedica.v27i4.170
World Health Organization.Global Report of the Ad Hoc Committee on the Tuberculosis Epidemic. WHO/TB/98.245. Geneva: World Health Organization; 1998. Fecha de consulta: 11 de agosto de 2013. Disponible en: http://apps.who.int/iris/bitstream/10665/63941/1/WHO_TB_98.245.pdf?ua=1.
Silva GE, Galeano E, Correa JO. Adherencia al trata-miento, implicaciones de la no-adherencia. Acta Med Colomb. 2005;30:268-73.
Culqui DR, Grijalva CG, Reategui SR, Cajo JM, Suárez LA. Factores pronósticos del abandono del tratamiento antituberculoso en una región endémica del Perú. Rev Panam Salud Pública. 2005;18:14-20. http://dx.doi.org/10. 1590/S1020-49892005000600003
Strauss A, Corbin J. Bases de la investigación cualitativa: técnicas y procedimientos para desarrollar la teoría fundamentada. Primera edición. Medellín: Universidad de Antioquia; 2002. p. 111-77.
Ministerio de la Protección Social. Decreto 3518 de 2006. Sistema de Vigilancia en Salud Pública. Fecha de consulta: 11 de agosto de 2013. Disponible en: http://www.ins.gov.co/lineas-de-accion/Subdireccion-Vigilancia/sivigila/Documentos%20SIVIGILA/Decreto%203518%2006%20Crea%20y%20reglamenta%20el%20SIVIGILA.pdf.
Ministerio de la Protección Social, Universidad Nacional de Colombia. Guía de atención de la tuberculosis pulmonar y extrapulmonar. Medicina & Laboratorio. 2011;17:3-4.
Malejczyk K, Gratnix J, Beckon A, Moreau D, Williams G, Kunimoto D. Factors associated with noncompeting of latent tuberculosis infection treatment in an inner-city population in Edmonton, Alberta. Can J Infect Dis Med Microbiol. 2014;25:281-4.
Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Med. 2007;4:238. http://dx.doi.org/10.1371/journal.pmed.0040238
Shiotani R, Hennink M. Socio-cultural influences on adherence to tuberculosis treatment in India. Glob Public Health. 2014;9:1239-51. http://dx.doi.org/10.1080/17441692.2014.953562
Kisambu J, Nuwaha F, Sekandi JN. Adherence to treatment and supervision for tuberculosis in a DOTS programme among pastoralists in Uganda. Int J tuberc Lung Dis. 2014;18:799-803. http://dx.doi.org/10.5588/ijtld.13.0753
Vijay S, Swaminatham S, Vaidayanathan P, Thomas A, Chauhan LS, Kumar P, et al. Feasibility of provider-initiated HIV testing and counselling of tuberculosis patients under the TB control programme in two districts of South India. PLoS One. 2009;4:e7899. http://dx.doi.org/10.1371/journal.pone.0007899
Muñoz AI, Rubiano YL, Laza C. Adherencia al tratamiento antituberculoso: voces de los implicados. Index Enferm. 2011;20:66-70. http://dx.doi.org/10.4321/S1132-129620110 00100014
Álvarez-Gordillo GC, Álvarez-Gordillo JF, Dorantes-Jiménez JE, Halperin-Frisch D. Percepciones y prác-ticas relacionadas con la tuberculosis y la adherencia al tratamiento en Chiapas, México. Salud Pública Mex. 2000;42:520-8. http://dx.doi.org/10.1590/S0036-3634200 0000600008
Rodríguez E, Mondragón CH. Adherencia a la terapia farmacológica y sus factores determinantes en pacientes con tuberculosis de un centro de salud de Santiago de Cali. Rev Colomb Cienc Quím Farm. 2014;43:104-19.
Williams A, Manias E, Walker R. Interventions to improve medication adherence in people with multiple chronic conditions: A systematic review. J Adv Nurs. 2008;63:132-43. http://dx.doi.org/10.1111/j.1365-2648.2008.04656.x
Dilla T, Valladares A, Lizán L, Sacristán JA. Adherencia y persistencia terapéutica: causas, consecuencias y estra-tegias de mejora. Aten Primaria. 2009;41:342-8. http://dx. doi.org/10.1016/j.aprim.2008.09.031
Muñoz A, Bertolozzi MR. Más allá del DOTS (Directly Observed Treatment Short-Course) en el control de la tuberculosis: medio que promueve la comunicación y la identificación de las necesidades. Rev Latino-Am Enfermagem. 2009;17:689-94. http://dx.doi.org/10.1590/S0104-11692009000500015
Finlay A, Lancaster J, Holtz TH, Weyer K, Miranda A, van der Walt M. Patient and provider-level risk factors associated with default from tuberculosis treatment. South Africa 2002: A case control study. BMC Public Health. 2012;12:56. http://dx.doi.org/10.1186/1471-2458-12-56
Heredia MR, PucFranco M, Caamal-Ley P, Vargas A. Determinantes sociales relacionados con el tratamiento de tuberculosis en Yucatán, México. Rev Biomed. 2012;23: 113-20.
González R, Lupercio A, Hidalgo G, León S, Salazar J. Calidad de vida relacionada con la salud y trabajo en pacientes con tuberculosis en Guadalajara (México). Salud Uninorte. 2013;29:13-21.
Some similar items:
- Juan Gabriel Bueno-Sánchez, Jairo René Martínez-Morales, Elena E. Stashenko, Wellman Ribón, Anti-tubercular activity of eleven aromatic and medicinal plants occurring in Colombia , Biomedica: Vol. 29 No. 1 (2009)
- María Consuelo Garzón, Dailyn Yorledy Angée, Claudia Llerena, Dora Leticia Orjuela, Jorge Ernesto Victoria, Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs , Biomedica: Vol. 28 No. 3 (2008)
- Diego Chaves, Andrea Sandoval, Luis Rodríguez, Juan C. García, Silvia Restrepo, María Mercedes Zambrano, Comparative analysis of six Mycobacterium tuberculosis complex genomes , Biomedica: Vol. 30 No. 1 (2010)
- María Imaz, Sonia Allassia, Mónica Aranibar, Alba Gunia, Susana Poggi, Ana Togneri, Lidia Wolff, Group of Implementation of Fluorescence, Performance of LED fluorescence microscopy for the detection of acid-fast bacilli from respiratory samples in peripheral laboratories in Argentina , Biomedica: Vol. 37 No. 2 (2017)
- Diana Castaño, Mauricio Rojas, Alterations in recruitment and activation of Rab proteins during mycobacterial infection , Biomedica: Vol. 30 No. 2 (2010)
- Adriana Rojas-Villarraga, Carlos Andrés Agudelo, Ricardo Pineda-Tamayo, Alvaro Porras, Gustavo Matute, Juan Manuel Anaya, Tuberculosis in patientes treated with tumor necrosis factor alpha antagonists living in an endemic area. Is the risk worthwhile? , Biomedica: Vol. 27 No. 2 (2007)
- Francisco Cuervo, Luis F. Giraldo, Alirio Bastidas, Carlos Vélez, Maria R. Forero, Fibrinogen-thrombin as bridge therapy in massive hemoptysis , Biomedica: Vol. 33 No. 1 (2013)
- Alvaro Javier ldrovo, Notes on the onset of a pulmonary tuberculosis epidemic in Bogotá (1870-1920) , Biomedica: Vol. 21 No. 3 (2001)
- Ivohne Fernanda Corrales, Jorge Alberto Cortés, María Lucía Mesa, Graciela Zamora, Sternal osteomyelitis and scrofuloderma due to BCG vaccination. , Biomedica: Vol. 23 No. 2 (2003)
- Alvaro Javier Idrovo, Historical, social and epidemiological roots of tuberculosis in Bogotá, Colombia. , Biomedica: Vol. 24 No. 4 (2004)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
